/
Other
Age
47
Pipeline Programs↗
28
Active Trials↗
44
Companies Involved↗
Age is a moderately active landscape with 47 programs across 44 companies. The most active players are Ascentage Pharma Group Inc., Sanofi, Getz Pharma. 5 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical35
Phase 24
Phase 35
Approved
No programs
Analysis
Modality Breakdown
91%
Small molecule
39 of 43 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 43 classified programs, each share of the total. Modality classified for 100% of 47 pipeline programs.
Analysis
Trial Status
279
clinical trials
Completed180 · 65%
Unknown status36 · 13%
Recruiting19 · 7%
Terminated17 · 6%
Withdrawn14 · 5%
Not yet recruiting5 · 2%
Other8 · 3%
Clinical Trials
Trial Activity
279 trials
Soaked Pharyngeal Packing Agents in Septoplasty
Recruiting·—·Phase 3·NCT07486544·90 enrolled
PET Image in PAH Patients
Recruiting·—·Phase 1·NCT05452889·71 enrolled
Colistin Dosage Prsonalization Approach
Recruiting·—·N/A·NCT06472271·100 enrolled
BMAC Loaded Collagen Jumping the Gap Around Immediate Implants
Recruiting·—·N/A·NCT05817526·20 enrolled
Page 1 of 19
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)